# An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer

> **NCT06129812** · — · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 1132 (actual)

## Conditions studied

- Pancreatic Cancer
- Neoadjuvant

## Interventions

- **DRUG:** Neoadjuvant treatment

## Key facts

- **NCT ID:** NCT06129812
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2021-12
- **Final completion:** 2021-12
- **Target enrollment:** 1132 (ACTUAL)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06129812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06129812, "An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06129812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*